Fig. 3
Kaplan–Meier survival curves stratified by (a) presence of endocrine/metabolic comorbidities (e.g., diabetes), (b) renal/genitourinary comorbidities, and (c) age group (\(\le 70\) vs. \(>70\) years).
Fig. 3 | Scientific Reports
Kaplan–Meier survival curves stratified by (a) presence of endocrine/metabolic comorbidities (e.g., diabetes), (b) renal/genitourinary comorbidities, and (c) age group (\(\le 70\) vs. \(>70\) years).
